Atopic dermatitis, cutaneous steroids and cataracts in children: two case reports
© Tatham; licensee BioMed Central Ltd. 2008
Received: 18 December 2007
Accepted: 28 April 2008
Published: 28 April 2008
Atopic dermatitis is a chronic, pruritic, eczematous skin disease mediated through an immediate (type I) hypersensitivity reaction. Posterior sub-capsular cataracts are a recognised complication of atopic dermatitis in adults; however they are rare in children. The management of atopic dermatitis is based on the exclusion of allergens, the use of emollients, and on topical corticosteroids for disease exacerbations. Cataracts may be due to atopic dermatitis but may also occur secondary to the use of corticosteroids.
We describe two children with atopic dermatitis, treated with cutaneous corticosteroids, both of whom were diagnosed with bilateral posterior sub-capsular cataracts.
These cases demonstrate that atopic dermatitis and topical corticosteroids may be associated with cataracts in children as well as adults. The cause of cataracts in atopic dermatitis is not known, however, it has been suggested that habitual tapping and rubbing of the face may play a role. Care needs to be taken when prescribing corticosteroids. Inadequate treatment of atopic dermatitis may lead to other ocular complications such as keratitis and permanent visual loss.
Atopic dermatitis (AD) is a chronic, pruritic, eczematous skin disease mediated through an immediate (type I) hypersensitivity reaction. It primarily affects the flexural surfaces and lesions exhibit a red, elevated, scaly and often excoriated appearance. AD is typically manifest in infants aged 1 to 6 months and 90% of eventual sufferers have had their first outbreak by age 5 years. Ocular complications of AD in adults include blepharitis, keratoconjunctivitis, keratoconus, uveitis, sub-capsular cataract and retinal detachment. Cataracts secondary to AD may occur in 25 to 50% of adults but are rare in adolescents and young adults . The most common ocular finding in children is a papillofollicular conjunctivitis . Two main types of cataract are seen in patients with AD, an anterior sub-capsular plaque and anterior and posterior sub-capsular opacities.
The management of AD is based on the exclusion of allergens, the use of emollients and on topical corticosteroids for disease exacerbations. Cataracts may be due to AD but may also occur secondary to the use of corticosteroids. The cataract associated with corticosteroids tends to be posterior sub-capsular. Ocular complications of corticosteroids may occur following intravenous, oral, inhaled or ocular administration. Although corticosteroids are commonly used in the treatment of dermatological diseases there are few reports of cataracts occurring following the use of cutaneous corticosteroids [1, 2].
We report two cases of children with AD who developed posterior sub-capsular cataracts.
Over the following 2 years, he developed a posterior sub-capsular cataract in his left eye (Figure 1B) and his vision reduced to light perception only. Cataract extraction and intra-ocular lens insertion was successfully performed on his left eye and his vision in now 6/6 in this eye. He continues to require 0.5% hydrocortisone to his face and 1% hydrocortisone on his arms.
The cataracts in these patients may have been due to the underlying disease, the treatment, or a combination of both. Cataracts secondary to AD are rare in children. In a series of 59 children, there was just one case of cataract . Why cataracts develop in patients with AD is not known, however, habitual tapping and rubbing of the face, a common problem in pruritic conditions, may play a role . Indeed, the presence of facial skin lesions in AD correlates with progression of the cataract . An alternative hypothesis suggests that the cataract is secondary to compromise of the blood-aqueous barrier. Patients with AD have been found to have higher levels of protein flare in the aqueous humour than controls . Posterior sub-capsular cataracts may also be caused by corticosteroids used in the treatment of AD.
The association between systemic corticosteroids and posterior sub-capsular cataracts was first noted by Black et al. . Subsequent studies have shown that corticosteroid-induced cataracts may develop following even small doses of steroids, particularly in children. Posterior sub-capsular cataract may occur at a faster rate and lower dosage in children . In addition to systemic steroids, cataracts have also been associated with ocular topical steroids, inhaled steroids and topical steroid creams [7, 8]. When steroids are applied topically to the skin, the degree of systemic absorption depends on factors such as drug potency, the duration of application and whether the skin is thin or damaged. Even low potency steroid creams applied to the eyelids may result in increased intra-ocular pressure and cataract .
The mechanism of corticosteroid-induced cataract is not known but may be due to osmotic imbalance, oxidative damage or disrupted lens growth factors . The osmotic theory suggests that corticosteroids interfere with the ionic composition of the lens. The oxidative theory proposes that corticosteroids inhibit the normal mechanisms that protect the lens from oxidative stress. Another theory of cataract formation proposes that steroids influence lens-related growth factors. Normal lens growth is mediated by growth factors such as fibroblast growth factor-2 present in the aqueous and vitreous humour . Corticosteroids may influence lens epithelial cell behaviour by interfering with the normal production of growth factors. This effect may result in undifferentiated anterior epithelial cells migrating and accumulating at the posterior pole forming a posterior sub-capsular cataract .
Cataract extraction in children with atopic cataract can produce excellent visual results, however, it is important to consider the presence of a coexisting retinal detachment. Retinal detachment has been reported in 8% of patients with AD and in one series, 25% of eyes with atopic cataract had retinal breaks or detachment noted pre-operatively . A rapidly progressing cataract may mask the presence of a shallow retinal detachment and an unrecognised retinal detachment can cause a mild cataract to progress faster. B-scan ultrasonography is a useful investigation to evaluate the anatomy of the retina in these eyes. Retinal detachment may also be associated with panuveitis or hypotony .
Corticosteroids are known to cause posterior sub-capsular cataract by most routes of administration. After diabetes, myopia and glaucoma, steroid use is the fourth leading risk factor for secondary cataract and accounts for 4.7% of all cataract extractions . Care needs to be taken when prescribing corticosteroids, particularly in children who have a lower susceptibility to side effects. Corticosteroids are frequently required to adequately treat AD, to limit pruritus and prevent complications such as keratitis that can lead to permanent visual loss. Exacerbations of AD need to be treated aggressively. Many patients and parents have negative perceptions regarding the use of steroids, which may lead to inadequate treatment of the skin disease and increased eye rubbing. The increasing use of alternative specific immunosuppressants that lack the side effect profile of corticosteroids may reduce the incidence of cataracts in these patients.
Written informed consent was obtained from the patients' parents for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Carmi E, Defossez-Tribout C, Ganry O: Ocular complications of atopic dermatitis in children. Acta Derm Venereol. 2006, 86: 515-517. 10.2340/00015555-0163.View ArticlePubMedGoogle Scholar
- Jobling AI, Augusteyn RC: What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom. 2002, 85: 61-75.View ArticlePubMedGoogle Scholar
- Nagaki Y, Hayasaka S, Kadoi C: Cataract progression in patients with atopic dermatitis. J Cataract Refract Surg. 1999, 25: 96-99. 10.1016/S0886-3350(99)80018-2.View ArticlePubMedGoogle Scholar
- Matsuo T, Saito H, Matsuo N: Cataract and aqueous flare levels in patients with atopic dermatitis. Am J Ophthalmol. 1997, 124: 36-39.View ArticlePubMedGoogle Scholar
- Black RL, Oglesby RB, von Sallman L, Bunim JJ: Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA. 1960, 174: 166-171.View ArticlePubMedGoogle Scholar
- Kaye LD, Kalenak JW, Price RL, Cunningham R: Ocular implications of long-term prednisolone therapy in children. J Pediatr Ophthalmol Strabismus. 1993, 30: 142-144.PubMedGoogle Scholar
- McLean CJ, Lobo RF, Brazier DJ: Cataracts, glaucoma and femoral avascular necrosis caused by topical corticosteroid ointment. Lancet. 1995, 345: 330-10.1016/S0140-6736(95)90324-0.View ArticlePubMedGoogle Scholar
- Cumming RG, Mitchell P, Leeder SR: Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med. 1997, 337: 8-14. 10.1056/NEJM199707033370102.View ArticlePubMedGoogle Scholar
- Garrott HM, Walland MJ: Glaucoma from topical corticosteroids to the eyelids. Clin Experiment Ophthalmol. 2004, 32 (2): 224-226. 10.1111/j.1442-9071.2004.00787.x.View ArticlePubMedGoogle Scholar
- Hayashi H, Igarashi C, Hayashi K: Frequency of ciliary body or retinal breaks and retinal detachment in eyes with atopic cataract. Br J Ophthalmol. 2002, 86: 898-901. 10.1136/bjo.86.8.898.View ArticlePubMedPubMed CentralGoogle Scholar
- Lim WK, Chee SP: Retinal detachment in atopic dermatitis can masquerade as acute panuveitis with rapidly progressive cataract. Retina. 2004, 24: 953-956. 10.1097/00006982-200412000-00017.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.